[White Paper] Workflow Strategies to Minimize Exposure to Hazardous Drugs in the Compounding Pharmacy

April 27, 2017 Bryan Prince

Minimize Exposure to Hazardous DrugsHandling hazardous drugs in the compounding pharmacy, per USP chapter <800> guidelines, involves strategic workflow strategies with the goal of minimizing personnel and environmental exposure. In our previous article, "Can A Class I and Class II Biological Safety Cabinet be in the Same Sterile Hazardous Room”  we discussed varying workflow methods and the potential for exposure points during the hazardous drug (HD) pre-sterilization process. Similarly, in our article titled “Facility and Engineering Controls Using USP 800 Guidelines” we discussed the synergistic relationship between the containment primary engineering control (C-PEC) and Good Lab Practices (GLP), mostly focusing on non-sterile rooms. The purpose of this article is to pull all of those chemical handlings and compounding workflow strategies together into a more sequential model in an effort to minimize personnel and environmental exposure. The main focus of this article is on nonsterile hazardous drug handling processes, but the principles of GLP are applicable with both sterile and nonsterile chemical handling. We would also make the assertion that there is a higher likelihood of surface and airborne contamination in the non-sterile compounding rooms due to the volume and activity of dry powders being handled.

About the Author

Bryan  Prince

Bryan Prince, MBA is the owner and lead consultant at Lab·Red Pharmacy Consultants. His early career in containment technology allowed him access to pharmaceutical labs around the U.S. where he gleaned extensive knowledge of chemical handling technique and safety strategies. In 2012 he started visiting compounding pharmacies to observe workflow habits and share his knowledge, which led to writing articles for the International Journal of Pharmaceutical Compounding (IJPC). Bryan has been invited to speak at conferences on “Quality, Safety, and Workflow in the Compounding Pharmacy” for the American College of Apothecaries and PCCA. Most recently he has spoken on "Facility and Engineering Controls Using USP 800 Guidelines" for the ACA and IACP. He is also a contributor to the ACHC’s USP 800 education conferences and webinars.

Follow on Linkedin Visit Website More Content by Bryan Prince
Previous Flipbook
[White Paper] Use of HEPA Filters in Biosafety Cabinets
[White Paper] Use of HEPA Filters in Biosafety Cabinets

Learn about the use of HEPA filters in biosafety cabinets.

Next Flipbook
[White Paper] USP 800 Gap Analysis, A Business Perspective
[White Paper] USP 800 Gap Analysis, A Business Perspective

USP 800 is going to financially impact your pharmacy’s future business model so this white paper focuses on...